USV is focused on developing solid oral and sterile dosage forms. In solid oral dosage forms, USV has capability of developing Tablets and Capsules using different manufacturing technologies for immediate as well as modified release drug delivery. In sterile dosage forms, USV has capability of developing injectable and ophthalmic solutions. The sterile dosage forms are filled in Vials, pre-filled syringes, cartridges, pen devices for injectable drug delivery and bottles used for ophthalmic drug delivery.
USV also has a state-of-the-art pilot lab to manufacture clinical supplies for investigational drugs.
USV currently holds 46 ANDAs and has 22 molecules filed in Europe.
160 plus dossier registrations & 40 dossiers under registration in APAC, MENA, SA, LATAM and CIS